27256491|t|Association between Leukoaraiosis and Poor Outcome is not due to Reperfusion Inefficiency after Intravenous Thrombolysis
27256491|a|Leukoaraiosis (LA) is associated with structural and functional cerebrovascular impairment, which may compromise the capacity of ischemic tissue to maximize reperfusion after intravenous thrombolysis (IVT). We aimed to determine whether severe LA is correlated with reperfusion inefficiency, which contributes to infarct growth and poor functional outcome. We analyzed data from our consecutive acute ischemic stroke (AIS) patients who had acquired baseline and 24-h follow-up diffusion- and perfusion-weighted imaging. Reperfusion was defined as reduction of ≥70 % of hypoperfusion lesion at 24 h from baseline. Severe LA was defined as Fazekas score 2 or 3 on FLAIR images. We investigated the relationship between severity of LA and reperfusion status. Multivariate statistical analysis was carried out for modeling the independent predictors of reperfusion, infarct growth, and functional outcome. Finally, 79 patients were included, among them 30 (37.97 %) had severe LA. Reperfusion was observed in 41 (51.89 %) patients, the proportion of reperfusion was very similar in patients with and without severe LA (53.33 vs 51.02 %, p = 1.000). Large artery occlusion was the only independent unfavorable predictor for reperfusion (OR = 0.202, 95 % confidence interval, 0.060-0.673; p = 0.014). Multiple linear regression analysis revealed that severe LA was independently associated with infarct growth (standardized coefficients = 0.191, p = 0.040). Severe LA was also an independent predictor of poor outcome (mRS ≥ 3) (OR = 4.004, 95 % confidence interval, 1.267-12.656, p = 0.018) after adjusting for reperfusion and baseline severity of stroke. Severe LA was associated with infarct growth and poor outcome independent of reperfusion status, which may expand the notion that LA contributes the intrinsic vulnerability of brain tissue to acute ischemic insults. The burden of LA may not serve as an imaging indicator of reperfusion inefficiency after IVT for AIS patients.
27256491	0	11	Association	T080	C0439849
27256491	20	33	Leukoaraiosis	T046	C0948163
27256491	38	50	Poor Outcome	T033	C3806166
27256491	65	76	Reperfusion	T038	C0684253
27256491	77	89	Inefficiency	T033	C0231184
27256491	96	120	Intravenous Thrombolysis	T061	C0040044
27256491	121	134	Leukoaraiosis	T046	C0948163
27256491	136	138	LA	T046	C0948163
27256491	143	158	associated with	T080	C0332281
27256491	159	169	structural	T037	C0270611
27256491	174	211	functional cerebrovascular impairment	T037	C0270611
27256491	238	246	capacity	T081	C1516240
27256491	250	258	ischemic	T169	C0475224
27256491	259	265	tissue	T024	C0040300
27256491	278	289	reperfusion	T038	C0684253
27256491	296	320	intravenous thrombolysis	T061	C0040044
27256491	322	325	IVT	T061	C0040044
27256491	358	364	severe	T080	C0205082
27256491	365	367	LA	T046	C0948163
27256491	387	398	reperfusion	T038	C0684253
27256491	399	411	inefficiency	T033	C0231184
27256491	434	448	infarct growth	T067	C2911660
27256491	453	476	poor functional outcome	T033	C3806166
27256491	516	537	acute ischemic stroke	T047	C0948008
27256491	539	542	AIS	T047	C0948008
27256491	544	552	patients	T101	C0030705
27256491	570	578	baseline	T081	C1442488
27256491	588	597	follow-up	T058	C1522577
27256491	598	608	diffusion-	T060	C0598801
27256491	613	639	perfusion-weighted imaging	T060	C4287652
27256491	641	652	Reperfusion	T038	C0684253
27256491	668	677	reduction	T061	C0441610
27256491	690	703	hypoperfusion	T046	C0442856
27256491	704	710	lesion	T033	C0221198
27256491	724	732	baseline	T081	C1442488
27256491	734	740	Severe	T080	C0205082
27256491	741	743	LA	T046	C0948163
27256491	759	772	Fazekas score	T081	C0449820
27256491	783	795	FLAIR images	T060	C4285947
27256491	817	829	relationship	T080	C0439849
27256491	838	846	severity	T080	C0439793
27256491	850	852	LA	T046	C0948163
27256491	857	868	reperfusion	T038	C0684253
27256491	877	889	Multivariate	T081	C0026777
27256491	890	910	statistical analysis	T062	C0871424
27256491	931	939	modeling	T062	C0870071
27256491	956	966	predictors	T078	C2698872
27256491	970	981	reperfusion	T038	C0684253
27256491	983	997	infarct growth	T067	C2911660
27256491	1003	1021	functional outcome	T169	C1274040
27256491	1035	1043	patients	T101	C0030705
27256491	1087	1093	severe	T080	C0205082
27256491	1094	1096	LA	T046	C0948163
27256491	1098	1109	Reperfusion	T038	C0684253
27256491	1114	1122	observed	T169	C1441672
27256491	1139	1147	patients	T101	C0030705
27256491	1167	1178	reperfusion	T038	C0684253
27256491	1199	1207	patients	T101	C0030705
27256491	1225	1231	severe	T080	C0205082
27256491	1232	1234	LA	T046	C0948163
27256491	1272	1288	artery occlusion	T046	C0264995
27256491	1326	1335	predictor	T078	C2698872
27256491	1340	1351	reperfusion	T038	C0684253
27256491	1370	1389	confidence interval	T081	C0009667
27256491	1416	1451	Multiple linear regression analysis	T170	C0034980
27256491	1466	1472	severe	T080	C0205082
27256491	1473	1475	LA	T046	C0948163
27256491	1494	1509	associated with	T080	C0332281
27256491	1510	1524	infarct growth	T067	C2911660
27256491	1539	1551	coefficients	T081	C1707429
27256491	1573	1579	Severe	T080	C0205082
27256491	1580	1582	LA	T046	C0948163
27256491	1607	1616	predictor	T078	C2698872
27256491	1620	1632	poor outcome	T033	C3806166
27256491	1661	1680	confidence interval	T081	C0009667
27256491	1727	1738	reperfusion	T038	C0684253
27256491	1743	1751	baseline	T081	C1442488
27256491	1752	1760	severity	T080	C0439793
27256491	1764	1770	stroke	T047	C0038454
27256491	1772	1778	Severe	T080	C0205082
27256491	1779	1781	LA	T046	C0948163
27256491	1786	1801	associated with	T080	C0332281
27256491	1802	1816	infarct growth	T067	C2911660
27256491	1821	1833	poor outcome	T033	C3806166
27256491	1849	1860	reperfusion	T038	C0684253
27256491	1902	1904	LA	T046	C0948163
27256491	1921	1944	intrinsic vulnerability	T033	C1821973
27256491	1948	1960	brain tissue	T023	C0459385
27256491	1964	1986	acute ischemic insults	T046	C0022116
27256491	2002	2004	LA	T046	C0948163
27256491	2025	2042	imaging indicator	T169	C1522602
27256491	2046	2057	reperfusion	T038	C0684253
27256491	2058	2070	inefficiency	T033	C0231184
27256491	2077	2080	IVT	T061	C0040044
27256491	2085	2088	AIS	T047	C0948008
27256491	2089	2097	patients	T101	C0030705